U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks

eXoZymes

Market Cap: US$81.4m

Operates as a development stage biotechnology company.

ICON

Market Cap: US$13.8b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Gilead Sciences

Market Cap: US$139.7b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Scholar Rock Holding

Market Cap: US$3.2b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

Bionano Genomics

Market Cap: US$18.0m

Provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Plus Therapeutics

Market Cap: US$48.6m

A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.

Enanta Pharmaceuticals

Market Cap: US$185.8m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

cbdMD

Market Cap: US$6.9m

Produces and distributes various cannabidiol (CBD) products in the United States.

Charles River Laboratories International

Market Cap: US$8.0b

Charles River Laboratories International, Inc.

Insight Molecular Diagnostics

Market Cap: US$71.8m

Operates as a precision diagnostics company in the United States and internationally.

Spruce Biosciences

Market Cap: US$4.2m

A biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.

Biohaven

Market Cap: US$1.6b

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.

Legend Biotech

Market Cap: US$6.3b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

BioVie

Market Cap: US$11.2m

A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.

NuCana

Market Cap: US$6.1m

A clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer.

Immunic

Market Cap: US$85.8m

A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.

Maravai LifeSciences Holdings

Market Cap: US$607.8m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Exagen

Market Cap: US$214.3m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Verona Pharma

Market Cap: US$9.1b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

Oncolytics Biotech

Market Cap: US$107.4m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

LakeShore Biopharma

Market Cap: US$33.0m

A biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer.

MIRA Pharmaceuticals

Market Cap: US$26.7m

Operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.

ALX Oncology Holdings

Market Cap: US$61.0m

A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.

PepGen

Market Cap: US$40.0m

A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

Immix Biopharma

Market Cap: US$66.0m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

Apellis Pharmaceuticals

Market Cap: US$3.5b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Zai Lab

Market Cap: US$3.6b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Twist Bioscience

Market Cap: US$1.6b

Manufactures and sells synthetic DNA-based products.

GeoVax Labs

Market Cap: US$18.9m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

Geron

Market Cap: US$912.4m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Regencell Bioscience Holdings

Market Cap: US$7.6b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.